March Innovation

News

Michael Bishop, Nobel-Winning Cancer

Researcher, Has Died at 90

He helped discover cancer-causing genes. Later, as chancellor of the University of California, San Francisco, he led a major expansion into Mission Bay.

Read About Michael Bishop

Demystifying Strategic Partnerships

UCSF Innovation Ventures is honored to have co-hosted such an impactful panel, “Demystifying Strategic Partnerships” with J&J Innovation. Great to hear perspectives on what makes a strong collaboration from a major player in the pharmaceutical ecosystem. Congratulations to the inspiring panelists – Juan Cueva, Chris Haskell, Lior Teitelbaum, and Lauren Gehman. And much gratitude to the moderator, Kathleen Wilson-Edell, who, together with Darya Bubman, organized this event for UCSF Innovation Ventures.

A big thank you to Mintz Law for co-sponsoring this program.

We are looking forward to continued engagement with J&J Innovation around promising NewCos at UCSF!

Innovative Events

UCSF Innovation Ventures congratulates all the Catalyst participants who pitched their technological discoveries on Monday, March 30, at Genentech Hall. This was by far one of the most impressive classes of candidates ever to present to our program.

22 teams working in Digital & Computational Health, Diagnostics, Therapeutics, and of course, Medical Devices. All could be the next successful breakthrough in healthcare technology. Our judges have their work cut out for them, so the finalists will only be announced at the end of April.

Huge thanks to the Catalyst Program and Innovation & Entrepreneurship team, Roopa Ramamoorthi, Nathanial Prorok, Praneeti Pathipati, Sohela Shah, Inder Takhar, and of course, Aenor Sawyer.

Truly impressive.

AI In Drug Discovery and the Life Sciences

Six-Part Series

Artificial Intelligence (AI) is transforming drug discovery and the life sciences. By accelerating research and expanding synthetic and analytical capabilities, AI is transforming how scientific insights are translated into products and therapies.

The law firm of Morrison Foerster (MoFo) will be at UCSF Mission Bay Campus, every Wednesday from March 4 through April 8, conducting a series of discussions about AI in Drug discovery from a legal perspective.

Understanding these issues is critical not only for legal professionals but also for scientists, founders, executives, investors, and institutional leaders working at the forefront of AI-enabled life sciences.

This series is co-sponsored by UCSF Small Molecule Discovery Center (SMDC), UCSF School of Pharmacy, UCSF Artificial Intelligence & Computational Drug Discovery & Development (AICD3), and UCSF Innovation Ventures.

Join this five-session expert-led masterclass for UCSF faculty and learners interested in advancing healthcare innovation.

The class will introduce the fundamentals of reimbursement and coding, providing essential knowledge to help innovators translate ideas into real-world healthcare impact.

Masterclass topics include:

Reimbursement Strategy • Coverage & Payment Models • CPT/HCPCS Coding • Medicare & Private Payers • Health Economics • Evidence for Coverage • Market Access • Digital Health Reimbursement • Device & Diagnostics Payment • Healthcare Payment Systems • Commercialization Pathways • Innovation Adoption

Registration required. Limited capacity.

Your registration implies a commitment to participate

in all 5 sessions

RSVP

For more information, please contact the course leads

Aenor Sawyer (aenor.sawyer@ucsf.edu) and Inder Takhar (inder.takhar@ucsf.edu)

Notable

UC Regents Value Innovation

UCSF Innovation Ventures represented the value of supporting frontline innovation with “Proof of Concept” funding at the UC Regents meeting on March 17.

We were well represented by the following UCSF Innovators: